| 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and … B Williams, G Mancia, W Spiering, E Agabiti Rosei, M Azizi, M Burnier, ... European heart journal 39 (33), 3021-3104, 2018 | 14970 | 2018 |
| 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the … J Knuuti, W Wijns, A Saraste, D Capodanno, E Barbato, ... European heart journal 41 (3), 407-477, 2020 | 7043 | 2020 |
| Update on myocarditis I Kindermann, C Barth, F Mahfoud, C Ukena, M Lenski, A Yilmaz, ... Journal of the American College of Cardiology 59 (9), 779-792, 2012 | 1218 | 2012 |
| Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study F Mahfoud, M Schlaich, I Kindermann, C Ukena, B Cremers, MC Brandt, ... Circulation 123 (18), 1940-1946, 2011 | 883 | 2011 |
| 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by … G Mancia Chairperson, M Brunström, M Burnier, G Grassi, A Januszewicz, ... Journal of hypertension 41 (12), 1874-2071, 2023 | 820* | 2023 |
| Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept … DE Kandzari, M Böhm, F Mahfoud, RR Townsend, MA Weber, S Pocock, ... The Lancet 391 (10137), 2346-2355, 2018 | 794 | 2018 |
| Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study H Krum, MP Schlaich, PA Sobotka, M Böhm, F Mahfoud, K Rocha-Singh, ... The Lancet 383 (9917), 622-629, 2014 | 788 | 2014 |
| Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled … RR Townsend, F Mahfoud, DE Kandzari, K Kario, S Pocock, MA Weber, ... The Lancet 390 (10108), 2160-2170, 2017 | 776 | 2017 |
| Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension MC Brandt, F Mahfoud, S Reda, SH Schirmer, E Erdmann, M Böhm, ... Journal of the American College of Cardiology 59 (10), 901-909, 2012 | 743 | 2012 |
| Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial M Azizi, RE Schmieder, F Mahfoud, MA Weber, J Daemen, J Davies, ... The Lancet 391 (10137), 2335-2345, 2018 | 675 | 2018 |
| Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension F Mahfoud, B Cremers, J Janker, B Link, O Vonend, C Ukena, D Linz, ... Hypertension 60 (2), 419-424, 2012 | 617 | 2012 |
| Expert consensus document from the European Society of Cardiology on catheter-based renal denervation F Mahfoud, TF Lüscher, B Andersson, I Baumgartner, R Cifkova, ... European Heart Journal 34 (28), 2149-2157, 2013 | 568 | 2013 |
| Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance A Yilmaz, I Kindermann, M Kindermann, F Mahfoud, C Ukena, ... Circulation 122 (9), 900-909, 2010 | 525 | 2010 |
| Authors/Task Force Members. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European … B Williams, G Mancia, W Spiering, E Agabiti Rosei, M Azizi, M Burnier, ... J Hypertens 36 (10), 1953-2041, 2018 | 524 | 2018 |
| Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension F Mahfoud, C Ukena, RE Schmieder, B Cremers, LC Rump, O Vonend, ... Circulation 128 (2), 132-140, 2013 | 507 | 2013 |
| ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension B Williams, G Mancia, W Spiering, E Agabiti Rosei, M Azizi, M Burnier, ... Eur Heart J 39 (33), 3021-3104, 2018 | 503 | 2018 |
| Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial M Böhm, K Kario, DE Kandzari, F Mahfoud, MA Weber, RE Schmieder, ... The Lancet 395 (10234), 1444-1451, 2020 | 476 | 2020 |
| Renal denervation in moderate to severe CKD D Hering, F Mahfoud, AS Walton, H Krum, GW Lambert, EA Lambert, ... Journal of the American Society of Nephrology 23 (7), 1250-1257, 2012 | 469 | 2012 |
| Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials M Böhm, H Schumacher, KK Teo, EM Lonn, F Mahfoud, JFE Mann, ... The Lancet 389 (10085), 2226-2237, 2017 | 372 | 2017 |
| Renal denervation suppresses ventricular arrhythmias during acute ventricular ischemia in pigs D Linz, K Wirth, C Ukena, F Mahfoud, J Pöss, B Linz, M Böhm, ... Heart rhythm 10 (10), 1525-1530, 2013 | 362 | 2013 |
Markus SchlaichDobney Hypertension Centre - Royal Perth Hospital Campus, University of Western Australia在 uwa.edu.au 的电子邮件经过验证
